An Exploratory Open-Label Study Of The Effects On Responsive Neurostimulator Eeg Epileptiform Activity After Intranasal Administration Of A Single Dose Of Valtoco® To People With Epilepsy With Previously Implanted Responsive Neurostimulator Systems
Posted Date: Nov 8, 2021
- Investigator: Michael Privitera
- Type of Study: Drug
The purpose of this research study is to find out if there is a decrease in Responsive Neurostimulator (RNS) recorded abnormal brain wave activity following a single dose of intranasal VALTOCO® (diazepam nasal spray).
Participants Must Be 18 Or Older, Weigh More Than 110 Pounds, And Have Rns Implanted For At Least 3 Months With Stable Settings For At Least 30 Days. Participants My Not Be Pregnant, Have History Of Substance Abuse Within The Previous 2 Years, And Use Recreational Or Medicinal Marijuana In The Prior 30 Days. The Study Team Will Review Other Eligibility Criteria With Anyone Interested In Participating.
For More Information: